Consolidated Statements Of Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Capital	Retained Earnings	Accumulated Other Comprehensive Income	Treasury Stock	Non-controlling Interest
Stockholders' equity at beginning of period at Dec. 31, 2019	$ 6,509,426	$ 2,560	$ 4,204,547	$ 4,744,120	$ 14,774	$ (2,987,808)	$ 531,233
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(293,286)			(304,623)			11,337
Dividends ($0.35 declared per common share)	(57,248)			(57,248)
Distributions to noncontrolling interest holders	(33,918)						(33,918)
Other comprehensive income (loss), net of tax	(26,923)				(26,923)
Issuance of common stock under incentive compensation plans			(2,037)			2,037
Equity-based compensation	6,330		5,824				506
Purchase of treasury stock	(1,062)					(1,062)
Purchase of HEP units for restricted grants	(145)						(145)
Contributions from noncontrolling interests	7,304						7,304
Stockholders' equity at end of period at Mar. 31, 2020	6,110,478	2,560	4,208,334	4,382,249	(12,149)	(2,986,833)	516,317
Stockholders' equity at beginning of period at Dec. 31, 2019	6,509,426	2,560	4,204,547	4,744,120	14,774	(2,987,808)	531,233
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(420,348)
Other comprehensive income (loss), net of tax	(4,672)
Stockholders' equity at end of period at Sep. 30, 2020	5,876,569	2,560	4,217,128	4,088,816	10,102	(2,982,463)	540,426
Stockholders' equity at beginning of period at Mar. 31, 2020	6,110,478	2,560	4,208,334	4,382,249	(12,149)	(2,986,833)	516,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(150,407)			(176,677)			26,270
Dividends ($0.35 declared per common share)	(57,182)			(57,182)
Distributions to noncontrolling interest holders	(17,090)						(17,090)
Other comprehensive income (loss), net of tax	14,374				14,374
Issuance of common stock under incentive compensation plans			(527)			527
Equity-based compensation	7,959		7,484				475
Purchase of treasury stock	(181)					(181)
Purchase of HEP units for restricted grants	(2)						(2)
Contributions from noncontrolling interests	5,959						5,959
Other	603		603
Stockholders' equity at end of period at Jun. 30, 2020	5,914,511	2,560	4,215,894	4,148,390	2,225	(2,986,487)	531,929
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	23,345			(2,401)			25,746
Dividends ($0.35 declared per common share)	(57,173)			(57,173)
Distributions to noncontrolling interest holders	(19,933)						(19,933)
Other comprehensive income (loss), net of tax	7,877				7,877
Issuance of common stock under incentive compensation plans			(6,131)			6,131
Equity-based compensation	7,932		7,365				567
Purchase of treasury stock	(2,107)					(2,107)
Purchase of HEP units for restricted grants	(2)						(2)
Contributions from noncontrolling interests	2,119						2,119
Stockholders' equity at end of period at Sep. 30, 2020	5,876,569	2,560	4,217,128	4,088,816	10,102	(2,982,463)	540,426
Stockholders' equity at beginning of period at Dec. 31, 2020	5,722,203	2,560	4,207,672	3,913,179	13,462	(2,968,512)	553,842
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	182,850			148,217			34,633
Dividends ($0.35 declared per common share)	(57,663)			(57,663)
Distributions to noncontrolling interest holders	(19,977)						(19,977)
Other comprehensive income (loss), net of tax	(8,804)				(8,804)
Issuance of common stock under incentive compensation plans			56			(56)
Equity-based compensation	9,770		9,088				682
Purchase of treasury stock	(12)					(12)
Purchase of HEP units for restricted grants	(68)						(68)
Contributions from noncontrolling interests	9,747						9,747
Stockholders' equity at end of period at Mar. 31, 2021	5,838,046	2,560	4,216,816	4,003,733	4,658	(2,968,580)	578,859
Stockholders' equity at beginning of period at Dec. 31, 2020	5,722,203	2,560	4,207,672	3,913,179	13,462	(2,968,512)	553,842
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	680,358
Other comprehensive income (loss), net of tax	(9,002)
Stockholders' equity at end of period at Sep. 30, 2021	6,329,539	2,560	4,232,504	4,453,366	4,460	(2,966,150)	602,799
Stockholders' equity at beginning of period at Mar. 31, 2021	5,838,046	2,560	4,216,816	4,003,733	4,658	(2,968,580)	578,859
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	194,767			168,850			25,917
Distributions to noncontrolling interest holders	(18,211)						(18,211)
Other comprehensive income (loss), net of tax	4,995				4,995
Issuance of common stock under incentive compensation plans			(2,629)			2,629
Equity-based compensation	11,372		10,845				527
Purchase of treasury stock	(479)					(479)
Purchase of HEP units for restricted grants	(2)						(2)
Contributions from noncontrolling interests	9,779						9,779
Other	(23)			(23)
Stockholders' equity at end of period at Jun. 30, 2021	6,040,244	2,560	4,225,032	4,172,560	9,653	(2,966,430)	596,869
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	302,741			280,787			21,954
Distributions to noncontrolling interest holders	(19,029)						(19,029)
Other comprehensive income (loss), net of tax	(5,193)				(5,193)
Issuance of common stock under incentive compensation plans			(402)			402
Equity-based compensation	8,521		7,874				647
Purchase of treasury stock	(122)					(122)
Contributions from noncontrolling interests	2,358						2,358
Other | Error Correction, Other	19			19
Stockholders' equity at end of period at Sep. 30, 2021	$ 6,329,539	$ 2,560	$ 4,232,504	$ 4,453,366	$ 4,460	$ (2,966,150)	$ 602,799